Can Merck (MRK) Deliver a Positive Surprise in Q4 Earnings?

Merck's (MRK) new products like Keytruda and Bridion are likely to drive sales in the fourth quarter. However, headwinds remain in the form of genericization of key drugs and increasing competition.